Mirum Pharmaceuticals (MIRM) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to $0.05.
- Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) rose 116.67% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.86, marking a year-over-year increase of 58.65%. This contributed to the annual value of -$1.85 for FY2024, which is 53.75% up from last year.
- Latest data reveals that Mirum Pharmaceuticals reported EPS (Weighted Average and Diluted) of $0.05 as of Q3 2025, which was up 141.67% from -$0.12 recorded in Q2 2025.
- Mirum Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $1.91 during Q4 2021, with a 5-year trough of -$1.94 in Q2 2023.
- In the last 3 years, Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.52 in 2024 and averaged -$0.57.
- Per our database at Business Quant, Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 151.83% in 2022 and then spiked by 116.67% in 2025.
- Over the past 5 years, Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at $1.91 in 2021, then tumbled by 151.83% to -$0.99 in 2022, then rose by 27.27% to -$0.72 in 2023, then spiked by 31.94% to -$0.49 in 2024, then spiked by 116.67% to $0.05 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.05 in Q3 2025, compared to -$0.12 in Q2 2025 and -$0.30 in Q1 2025.